billHR10370Event Monday, September 14, 2026Analyzed

To better coordinate Federal efforts to utilize advance technologies, such as artificial intelligence, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer, and for other purposes.

Neutral

Summary

HR10370, introduced in the House on September 14, 2026, aims to coordinate federal efforts to apply advanced technologies, including artificial intelligence, to improve pediatric cancer diagnosis, treatment, and prevention. The bill is in the early legislative stage, referred to the House Energy and Commerce Committee, with no funding specified. It signals potential tailwinds for AI-driven healthcare and diagnostics companies, though near-term market impact is limited.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR10370 is an early-stage bill with no funding amount, limiting immediate market impact.
  • 2.The bill targets AI and advanced technologies in pediatric cancer, potentially benefiting AI diagnostics and precision medicine firms.
  • 3.Legislative momentum is low; the bill requires committee action and further votes to become law.
  • 4.No real market data was provided; analysis is based on structural positioning.

Market Implications

The bill's introduction adds to the narrative of federal support for AI in healthcare, but without funding or specific procurement mechanisms, it does not yet alter company fundamentals. Investors should watch for committee action and potential amendments that could introduce funding or program details. Companies with AI-driven diagnostics, such as $VEEV and $TDOC, may see sentiment lift if the bill progresses, but the absence of a direct causal chain means no ticker meets the confidence threshold for inclusion.

Full Analysis

HR10370 was introduced on September 14, 2026, by Rep. McCaul (R-TX-10) and referred to the House Committee on Energy and Commerce. The bill seeks to coordinate federal efforts to utilize advanced technologies, such as AI, for pediatric cancer research and care. As an early-stage bill with no funding authorization or appropriation specified, it is procedural and unlikely to have immediate market impact. However, it reflects a growing legislative focus on AI in healthcare, which could benefit companies with established AI diagnostics and precision medicine capabilities. The bill's path forward includes committee hearings, potential markup, and floor votes in both chambers—a process that could take months or longer. For investors, the key is to monitor whether the bill gains traction and whether future amendments add funding or specific program mandates. The convergence with other AI-in-healthcare initiatives suggests a broader federal push, but this bill alone does not yet create a direct revenue stream for any company.

Key Legislators

Rep. McCaul, Michael T. [R-TX-10]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 26, 2026

Declaring a National Emergency to Secure the United States Bulk-Power System

This executive order declares a national emergency to restrict foreign-produced bulk-power system electric equipment that poses national security risks, prohibiting new transactions involving equipment from covered foreign entities and allowing the Secretary of Energy to impose conditions on existing equipment. It directs the Secretary of Energy, in coordination with multiple agencies, to identify, mitigate, and potentially replace risky equipment, and establishes a pre-qualification list for approved vendors.

presidential_memorandumAug 20, 2026

The National Space Transportation Policy

This memorandum directs multiple agencies to expand and modernize U.S. space launch and reentry infrastructure to support over 1,000 launches annually by 2030, expedite permitting and environmental reviews, develop new federal reentry sites, and strengthen the space transportation industrial base. It mandates range scheduling transparency, spectrum reliability, and workforce development, with specific reports and plans due within 90 to 240 days.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →